EUVIMEDEUVIMED entdecken
Open Access

Evolution of Cryptococcal Antigen Testing: What Is New?

Elizabeth Nalintya, Reuben Kiggundu, David Meya

Current Fungal Infection Reports · 2016-06 · 10 (2) · 62-67

DOI: 10.1007/s12281-016-0256-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Fungal Infection Reports, online erschienen am 12.04.2016. Verfasst von Elizabeth Nalintya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Institute, Mulago Hill Road, Makerere University, Uganda. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CGH CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the last decade, an upsurge in both the frequency and severity of fungal infections due to the HIV/AIDS epidemic and the use of immunosuppressive therapy has occurred. Even diagnostic methods like culture and microscopy, which have low sensitivity and longer turn-around-times are not widely available, leading to delays in timely antifungal therapy and detrimental patient outcomes. The evolution of cryptococcal antigen (CrAg) testing to develop inexpensive and more sensitive methods to detect cryptococcal antigen is significant. These newer tests employ immunoassays as part of point-of-care platforms, which do not require complex laboratory infrastructure and they have the potential to detect early disease and reduce time to diagnosis of cryptococcal infection. Advocacy for widely available and efficacious life-saving antifungal treatment should be the only remaining challenge.

Schlagwörter

Stichwörter der Autor:innen

CryptococcusFungusHIVantigenassaycryptococcal diseasecryptococcal meningitisdiagnosislateral flowtestingthermal contrast

Autor:innen und Institutionen

  • Infectious Diseases Institute, Mulago Hill Road, Makerere University, Uganda.
  • Infectious Diseases Institute, Mulago Hill Road, Makerere University, Uganda.; Department of Medicine, Center for Infectious Diseases and Microbiology Translational Research, University of Minnesota, USA.; School of Med…

Förderung

  • CGH CDC HHS

Zitieren

APA

Nalintya, E., Kiggundu, R., & Meya, D. (2016). Evolution of Cryptococcal Antigen Testing: What Is New?. Current Fungal Infection Reports, 10(2), 62-67. https://doi.org/10.1007/s12281-016-0256-3

Vancouver

Nalintya E, Kiggundu R, Meya D. Evolution of Cryptococcal Antigen Testing: What Is New?. Current Fungal Infection Reports. 2016;10(2):62-67. doi:10.1007/s12281-016-0256-3

BibTeX
@article{Nalintya2016,
  author = {Nalintya, Elizabeth and Kiggundu, Reuben and Meya, David},
  title = {Evolution of Cryptococcal Antigen Testing: What Is New?},
  journal = {Current Fungal Infection Reports},
  year = {2016},
  volume = {10},
  number = {2},
  pages = {62--67},
  doi = {10.1007/s12281-016-0256-3}
}
Kostenlos starten →